Actively Recruiting
A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health
Led by ResBiotic Nutrition, Inc. · Updated on 2025-09-09
80
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
Sponsors
R
ResBiotic Nutrition, Inc.
Lead Sponsor
A
Able Biolabs, LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to evaluate the impact of a specific oral postbiotic supplement on metabolic health in overweight adults.
CONDITIONS
Official Title
A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide voluntary signed and dated informed consent.
- Be in good health as determined by medical history.
- Age between 18 and 65 yr (inclusive).
- Body Mass Index of 25.0 - 40.0 (inclusive).
- Subject agrees to maintain existing dietary and physical activity patterns throughout the study period.
- Agree to refrain from other probiotic and postbiotic supplement products throughout the duration of the trial.
- Subject is willing and able to comply with the study protocol.
- Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
You will not qualify if you...
- History of unstable or new-onset cardiovascular/cardiorespiratory, liver, or renal conditions.
- Alcohol abuse (more than 2 standard alcoholic drinks per day or more than 10 drinks per week) or drug abuse or dependence within the past 6 months.
- Previous bariatric surgery.
- Current smokers or smoking within the past month.
- History of hyperparathyroidism or an untreated thyroid condition.
- History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).
- Other known gastrointestinal or metabolic conditions that might impact nutrient absorption or metabolism, e.g., short bowel syndrome, irritable bowel syndrome (IBS), diarrheal illnesses, history of colon resection, gastroparesis, Inborn-Errors-of-Metabolism (such as PKU).
- Chronic inflammatory condition (e.g., rheumatoid arthritis, Crohn's, ulcerative colitis, Lupus, HIV/AIDS, etc.).
- Previous medical diagnosis of gout or fibromyalgia.
- Pregnant women, women trying to become pregnant, women less than 120 days postpartum or nursing women. Any woman that is sexually active will have to take report their pregnancy status prior to enrolling and during the trial if they become pregnant.
- Known sensitivity to any ingredient in the test formulations as listed in the product label.
- Currently participating in another research study with an investigational product or have been in another research study in the past 30 days.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Able Biolabs, LLC
Birmingham, Alabama, United States, 35203
Actively Recruiting
Research Team
P
Project Manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here